Back to News
Market Impact: 0.25
ASP Isotopes Targets $300M EBITDA as Helium, Silicon-28 and Radiopharmacy Plans Advance
Source: marketbeat.com
Company FundamentalsCorporate Guidance & OutlookHealthcare & BiotechCommodities & Raw Materials
ASP Isotopes CEO Paul Mann outlined plans to expand the company’s isotope-enrichment, radiopharmacy and helium businesses. The company is targeting more than $300 million in EBITDA by 2031; the article provides no interim milestones or realized results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
ASPI0.55
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Microsoft’s strong quarter backs up its stock rebound. Here's our new price target